AstraZeneca’s coronavirus vaccine trial will continue after officials found no safety issues despite the death of a Brazilian subject, the University of Oxford announced Wednesday.Oxford, which is developing the drug with AstraZeneca, said that officials have conducted an assessment of the death and “there have been no concerns about safety of the clinical trial.””The independent review in addition to the Brazilian regulator have recommended…
More Stories
Brazil rolls out COVID-19 vaccination plan
First Pfizer COVID-19 vaccine shipments to be delivered to US distribution sites starting Monday
CDC advisory panel recommends Covid-19 vaccine for people 16 and over